HALO logo
halo search icon
AFT
AFT Pharmaceuticals Ltd.

AFT · AFT Pharmaceuticals Ltd.

3.67

NZD
-0.08 (-2.13%)
25/06/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

NZ$393.28M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

18%

MQV Rating

1Very Strong

As at 25/06/2026 12:00:00 AM

Price Chart

Description

AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. It operates through the following geographical segments: Australia, New Zealand, Asia, and Rest of the World. The Australia segment caters to the Australian market. The New Zealand segment focuses on the head office function, supplier relationships and procurement of stock, and regulatory, marketing, and finance activities of the group. The Asia segment relates in the sales activities in Brunei, Hong Kong, Malaysia, Philippines, Singapore, and Vietnam markets. The Rest of the World segment consists of out licensing of internet protocol developments to markets in which the firm does not have a presence and the export of products to export markets. The company was founded by Hartley Atkinson and Marree Atkinson on September 4, 1997 and is headquartered in Auckland, New Zealand.

  • All-Companies
  • All-Consensus
  • HALO 100
  • HALO All
  • HALO Capital Efficiency
  • HALO Dividend Growth
  • HALO GARP
  • HALO MQV
  • HALO MQV SMALL
  • HALO Small

Key Fundamentals

EPS 3 yr Growth

-5.90%

EBITDA Margin

11.00%

Operating Cashflow

-$12m

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Performance

52 weeks range

Low 2.54 - 3.98

Trade Value (12mth)

US$8,112.00

1 week

-2.39%

1 month

-5.9%

YTD

8.58%

1 year

43.36%

All time high

5.65

Additional Data

Shares Outstanding (Fully Diluted)

105m

HALO Sector

Healthcare

Next Company Report Date

24-May-27

Next Ex Dividend Date

18-Jun-26

Next Dividend Pay Date

03-Jul-26

Reporting Currency

NZD

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Very Strong

Garp

Strong

Mqv Small

Very Strong

Momentum

Price

Weak

Earnings

Strong

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Neutral

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of AFT Pharmaceuticals Ltd. (AFT:NZE)?
Halo FAQ
The current share price of AFT Pharmaceuticals Ltd. (AFT:NZE) is NZDNZ$3.67.
2
What is the 52-week high share price for AFT Pharmaceuticals Ltd. (AFT:NZE)?
Halo FAQ
The 52-week high share price for AFT Pharmaceuticals Ltd. (AFT:NZE) is NZDNZ$3.98.
3
What is the 52-week low share price for AFT Pharmaceuticals Ltd. (AFT:NZE)?
Halo FAQ
The 52-week low share price for AFT Pharmaceuticals Ltd. (AFT:NZE) is NZDNZ$2.54.
4
What is the dividend yield for AFT Pharmaceuticals Ltd. (AFT:NZE)?
Halo FAQ
AFT Pharmaceuticals Ltd. (AFT:NZE) does not pay a dividend.
5
What was AFT Pharmaceuticals Ltd. (AFT:NZE) last dividend payment?
Halo FAQ
The last dividend payment of AFT Pharmaceuticals Ltd. (AFT:NZE) is NZDNZ$0.03.
6
What is the franking level for AFT Pharmaceuticals Ltd. (AFT:NZE)?
Halo FAQ
AFT Pharmaceuticals Ltd. (AFT:NZE) has a franking level of 0.00%.
7
In which sector is AFT Pharmaceuticals Ltd. (AFT:NZE) classified?
Halo FAQ
AFT Pharmaceuticals Ltd. (AFT:NZE) is classified in the Healthcare.